logo

PRTA

Prothena·NASDAQ
--
--(--)
--
--(--)
4.10 / 10
Netural

Fundamental score: 4.1/10 indicating moderate quality. Bullish factors include Revenue-MV, Profit-MV, Cash-MV, and Gross profit margin (%). Caution is warranted for Current assets turnover ratio and Fixed assets turnover ratio, which show weak performance. Overall assessment: constrained.

Fundamental(4.1)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-3.51
Score2/3
Weight19.49%
1M Return11.69%
Inventory turnover ratio
Value47.85
Score3/3
Weight7.50%
1M Return5.26%
Gross profit margin (%)
Value100.00
Score3/3
Weight17.16%
1M Return10.80%
Profit-MV
Value0.46
Score2/3
Weight12.79%
1M Return7.79%
PB-ROE
Value0.44
Score0/3
Weight5.84%
1M Return3.56%
Current assets turnover ratio
Value0.02
Score0/3
Weight-2.34%
1M Return-1.88%
Fixed assets turnover ratio
Value0.77
Score1/3
Weight-2.03%
1M Return-1.64%
Asset-MV
Value-0.50
Score2/3
Weight29.17%
1M Return15.13%
Cash-MV
Value-0.07
Score2/3
Weight12.80%
1M Return7.73%
Net profit / Total profit (%)
Value124.13
Score0/3
Weight-0.38%
1M Return-0.30%
Is PRTA fundamentally strong?
  • PRTA scores 4.10/10 on fundamentals and holds a Fair valuation at present. Backed by its -56.91% ROE, -2379.59% net margin, -1.71 P/E ratio, 1.63 P/B ratio, and -111.38% earnings growth, these metrics solidify its Netural investment rating.